Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritisJasper J. Haringman, Paul P. Tak, Daniëlle M. Gerlag et al.|Annals of the Rheumatic Diseases|2004Cited by 464
A randomized controlled trial with an anti‐CCL2 (anti–monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritisJasper J. Haringman, Paul P. Tak, Dominique Baeten et al.|Arthritis & Rheumatism|2006Cited by 255
Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritisDaniëlle M. Gerlag, Paul P. Tak, Jasper J. Haringman et al.|Arthritis & Rheumatism|2004Cited by 155
Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: Implications for use of synovial sublining macrophages as a biomarkerCarla A. Wijbrandts, Paul P. Tak, Clarissa E. Vergunst et al.|Arthritis & Rheumatism|2007Cited by 114
Reliability of computerized image analysis for the evaluation of serial synovial biopsies in randomized controlled trials in rheumatoid arthritisJasper J. Haringman, Paul P. Tak, Marjolein Vinkenoog et al.|Arthritis Research & Therapy|2005Cited by 76